2012
DOI: 10.1016/j.bmcl.2012.01.133
|View full text |Cite
|
Sign up to set email alerts
|

A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
25
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 46 publications
(25 citation statements)
references
References 24 publications
0
25
0
Order By: Relevance
“…13 We were intrigued by the physical similarity between our DHPM derivatives and the related structures 2 , which were described to possess inhibitory activity toward HIV replication in cells, although no MOA has been reported. 13 We therefore designed a biological testing funnel to narrow down the target of the DHPMs (Fig. 2).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…13 We were intrigued by the physical similarity between our DHPM derivatives and the related structures 2 , which were described to possess inhibitory activity toward HIV replication in cells, although no MOA has been reported. 13 We therefore designed a biological testing funnel to narrow down the target of the DHPMs (Fig. 2).…”
Section: Resultsmentioning
confidence: 99%
“…11,12 A comprehensive analysis of published bioactivities of DHPMs with some similarity to our derivatives led us to investigate activity against human immunodeficiency virus (HIV), 13 a therapeutic target that is amenable to phenotypic screening. HIV is the causative agent of acquired immunodeficiency syndrome (AIDS), a disease for which there is no cure.…”
Section: Introductionmentioning
confidence: 99%
“…For example, approach, which is based on bromination and a subsequent nucleophilic replacement reaction, is well documented. 6‐Bromo‐ and 6‐dibromomethyl‐3,4‐dihydropyrimidines are a versatile, readily accessible building blocks for the synthesis of furo[3,4‐ d ]pyrimidines , pyrrolo[3,4‐ d ]pyrimidines , pyrimido[4,5‐ d ]pyridazines , thiazolo[3,4‐ c ]pyrimidine , and cyclopenta[d]pyrimidine .…”
Section: Intramolecular Cycloadditions Of Partially Saturated Pyrimidmentioning
confidence: 99%
“…Biginelli reaction takes place by mixing different substituted aldehydes, urea or thiourea, and an active 1,3-dicarbonyl compound in combination with different catalytic systems such as AcOH [14], ZrCl 4 [15], Cu(OTf) 2 [16], SiO 2 /H 2 SO 4 [17], La(OTf) 3 [18], CdCl 2 [19], 1-n-butyl-3-methyl imidazolium tetrafluoroborate [20], SiO 2 /NaHSO 4 [21], Pb(NO 3 ) 2 [22], NaCl [23], KSF clay [24], FeCl 3 [25], BiCl 3 [26], ion-exchange resin [27], LiBr [28] [32], Mn(OAc) 3 [33], InBr 3 [ 34], microwave [35][36][37][38] or ultrasound irradiation [39] and solvent-free conditions [40], Co(NO 3 ) 2 .6H 2 O [41], ZnCl 2 /TBAB [42]. In the last two decades microwave mediated reactions have been of great interest in organic synthesis because of their shorter reaction times and high yields of products with good selectivity.…”
Section: Introductionmentioning
confidence: 99%
“…The limited availability of the natural products renders them to be attractive targets for total synthesis [3]. The dihydropyrimidinone (DHPM) is the most important core structure in the synthesis of different medicinally and pharmacologically valuable agents such as antibacterial [4], antiviral [5], antitumor [6], antihypertensive agents [7], calcium channel blockers [8], neuropeptide Y (NPY) antagonists [9], α-1a-antagonists [10] and anti-inflammatory drugs [11].…”
Section: Introductionmentioning
confidence: 99%